Maintain pressure on reforms to protect NHSDiabetes drug aids weight loss
A new treatment for patients with type 2 diabetes, designed to be administered quickly and conveniently and encourage weight loss, is being launched in the UK
Victoza - also known as liraglutide - is a once-a-day injection that not only controls blood sugar levels, but also exaggerates the ‘full’ feeling that users have after eating to help suppress hunger.
Anthony Barnett, clinical director of diabetes and endocrinology at the Heart of England NHS Foundation Trust in Birmingham, said: ‘With Victoza, patients with type 2 diabetes can be confident they are controlling their blood sugar, and may benefit from weight loss.’
‘This is an important advance for patients with type 2 diabetes, many of whom are already overweight.’
There are currently two million people diagnosed with type 2 diabetes in the UK with an estimated 500,000 more unaware that they have the disease.
Cathy Moulton, care advisor at Diabetes UK, said: ‘Victoza widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss.’
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.